The Real-World Use of Semaglutide to Promote Weight Loss in Obese Adults With Hemodialysis: A Multicenter Cross-Sectional Descriptive Study

Background: Obesity can be an issue for renal transplant eligibility. Semaglutide constitutes an interesting choice for obesity treatment, but little data exist regarding its efficacy and security among dialysis patients. Objectives: The co-primary endpoints of this study were to describe the change...

Full description

Saved in:
Bibliographic Details
Main Authors: Jodianne Couture, Pascale Robert, Marie-France Beauchesne, Gabriel Dallaire, Annie Lizotte, Jo-Annie Lafrenière, Julie Beauregard, Janique Doucet
Format: Article
Language:English
Published: SAGE Publishing 2025-03-01
Series:Canadian Journal of Kidney Health and Disease
Online Access:https://doi.org/10.1177/20543581251324588
Tags: Add Tag
No Tags, Be the first to tag this record!